Aurobindo Pharma inches up on reporting 33% rise in Q2 consolidated net profit
Aurobindo Pharma is currently trading at Rs. 1796.00, up by 7.70 points or 0.43% from its previous closing of Rs. 1788.30 on the BSE.
The scrip opened at Rs. 1771.30 and has touched a high and low of Rs. 1805.00 and Rs. 1771.30 respectively. So far 35591 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 1,805.00 on 06-Nov-2026 and a 52 week low of Rs. 1106.25 on 10-Feb-2026.
Last one week high and low of the scrip stood at Rs. 1,805.00 and Rs. 1650.10 respectively. The current market cap of the company is Rs. 102725.09 crore.
The promoters holding in the company stood at 51.88%, while Institutions and Non-Institutions held 41.83% and 6.29% respectively.
Aurobindo Pharma has reported a 24.46% rise in its net profit at Rs 723.58 crore for the second quarter ended September 30, 2026 (Q2FY27) as compared to Rs 581.37 crore for the same quarter in the previous year. Total income increased by 13.52% to Rs 3,280.13 crore for Q2FY27 as compared to Rs 2,889.45 crore for the corresponding quarter of the previous year.
On a consolidated basis, the company has reported a 32.72% rise in its net profit at Rs 1,126.08 crore for Q2FY27, as compared to Rs 848.45 crore for the same quarter in the previous year. Total income increased by 24.09% to Rs 10,431.51 crore for Q2FY27 as compared to Rs 8,406.29 crore for the corresponding quarter of the previous year.
